Loading stock data…
Corteva (CTVA)
$89.25+0.47 (+0.53%)
Market ClosedLast close Jul 24
Corteva, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Corteva, Inc. in the Basic Materials sector is trading at $89.25 with a market capitalization of $50.8B. Wall Street consensus targets $91.10 (20 analysts), implying a +2.1% move over the next 12 months. The stock is currently near its 52-week high of $89.39, remaining 20.0% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.91B↑ | $3.91B↑ | $2.62B↓ | $6.46B↑ | $4.42B |
| Gross Profit | $2.53B↑ | $1.66B↑ | $974.00M↓ | $3.52B↑ | $2.08B |
| Operating Income | $1.16B↑ | $242.00M↑ | -$270.00M↓ | $1.83B↑ | $827.00M |
| Net Income | $720.00M↑ | -$552.00M↓ | -$320.00M↓ | $1.31B↑ | $652.00M |
Peer Comparison
Fundamentals
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait techno...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$50.77B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.61%
ROE
Average efficiency. Growth may require heavy reinvestment.
4.77%
Volume
Today's trading volume
1.89M
Recent News
Corteva, Inc. (CTVA) Upgraded to Buy: Here's What You Should Know
Corteva, Inc. (CTVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Corteva Set to Report Q2 Earnings: What Investors Should Expect
CTVA's Q2 earnings may rise as premium seed demand, new products and productivity gains help offset pricing and inflation pressures.
Corteva (CTVA) Dividend Reaffirmed As Earnings Beat Hopes Keep Valuation In Focus
Dividend affirmation and earnings expectations set the tone Corteva (CTVA) has reaffirmed a common stock dividend of $0.18 per share, payable on September 15, 2026. This announcement comes as analysts highlight expectations for higher earnings and revenue in the upcoming June quarter report. See our latest analysis for Corteva. Corteva’s recent momentum has been strong, with a 12.22% 1 month share price return and a 31.02% year to date share price return. The 5 year total shareholder return...
Corteva (CTVA) Stock Looks Like A Bargain On Cash Flow, Priced For Perfection On Earnings
Corteva stock has more than doubled over the past five years, yet its valuation signals are pulling in different directions, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a discount while market based multiples suggest the shares are on the rich side. Corteva has delivered a 116.8% return over the past five years, which puts extra focus on whether the current share price still reflects a reasonable entry point. Expectations that Corteva can keep converting its...
Does Rising Confidence In a 2026 Earnings Beat Change The Bull Case For Corteva (CTVA)?
Corteva, Inc. recently drew increased analyst attention as expectations rose that its June 2026 quarter would exceed prior earnings forecasts on higher revenues. Analysts are highlighting Corteva’s history of topping consensus earnings estimates and a positive Earnings ESP, which together are fueling confidence ahead of its upcoming report. We’ll now examine how analysts’ growing confidence in a potential earnings beat could reshape key elements of Corteva’s longer-term investment...